We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Xcel Energy
XEL
$50.1B
| $16.5M | 0.03% |
511,226
-164,489
| -24% | -$5.1M |
|
|
KS
277
DELISTED
KapStone Paper and Pack Corp.
KS
| $16.2M | 0.03% |
488,197
+35,042
| +8% | +$995K |
|
278
Applied Industrial Technologies
AIT
$12.9B
| $15.7M | 0.03% |
+309,746
| New | +$15M |
|
279
Itaú Unibanco
ITUB
$91.6B
| $15.6M | 0.03% |
2,710,188
+265,760
| +11% | +$1.56M |
|
280
AvalonBay Communities
AVB
$27.2B
| $15.5M | 0.03% |
108,735
-2,206
| -2% | -$305K |
|
|
AET
281
DELISTED
Aetna Inc
AET
| $15.2M | 0.03% |
186,898
+9,931
| +6% | +$752K |
|
|
ICON
282
DELISTED
Iconix Brand Group, Inc.
ICON
| $15M | 0.03% |
35,029
-12,730
| -27% | -$5.25M |
|
283
Carter's
CRI
$1.45B
| $15M | 0.03% |
218,119
+127,817
| +142% | +$9.28M |
|
|
SZYM
284
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $15M | 0.03% |
1,271,317
+881,365
| +226% | +$9.4M |
|
285
CMS Energy
CMS
$23B
| $14.8M | 0.03% |
476,735
-58,915
| -11% | -$1.75M |
|
286
iShares Core S&P Small-Cap ETF
IJR
$110B
| $14.8M | 0.03% |
264,426
-437,856
| -62% | -$23.7M |
|
|
SPWR
287
DELISTED
SunPower Corporation Common Stock
SPWR
| $14.7M | 0.03% |
548,802
+443,401
| +421% | +$9.7M |
|
|
LHO
288
DELISTED
LaSalle Hotel Properties
LHO
| $14.5M | 0.03% |
411,049
+104,217
| +34% | +$3.46M |
|
|
JEQ
289
DELISTED
abrdn Japan Equity Fund
JEQ
| $14.5M | 0.03% |
2,036,701
-374,071
| -16% | -$2.5M |
|
|
MXE
290
Mexico Equity and Income Fund
MXE
$58.5M
| $14.4M | 0.03% |
894,766
-71,797
| -7% | -$1.1M |
|
291
Cemex
CX
$17.3B
| $14.3M | 0.03% |
1,218,257
+226,599
| +23% | +$2.58M |
|
292
Invesco
IVZ
$13B
| $14.2M | 0.03% |
377,310
-23,915
| -6% | -$865K |
|
|
CTRA
293
DELISTED
Coterra Energy
CTRA
| $14.1M | 0.03% |
414,376
+306,711
| +285% | +$11M |
|
|
WR
294
DELISTED
Westar Energy Inc
WR
| $14.1M | 0.03% |
368,811
-32,125
| -8% | -$1.15M |
|
295
Berkshire Hathaway Class B
BRK.B
$1.11T
| $13.9M | 0.03% |
110,069
+18
| +0% | +$2.28K |
|
|
EPE
296
DELISTED
EP Energy Corporation
EPE
| $13.9M | 0.03% |
602,583
-60,004
| -9% | -$1.21M |
|
|
TFCFA
297
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $13.7M | 0.03% |
+391,175
| New | +$13.3M |
|
|
LDF
298
DELISTED
Latin American Discovery Fund
LDF
| $13.5M | 0.03% |
982,860
-18,187
| -2% | -$246K |
|
|
TIVO
299
DELISTED
Tivo Inc
TIVO
| $13.5M | 0.03% |
561,793
+493,750
| +726% | +$11.5M |
|
300
OneMain Financial
OMF
$7.19B
| $13.3M | 0.03% |
513,546
-28,493
| -5% | -$698K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.